Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,789,412
-
Total 13F shares
-
62,930
-
Share change
-
+29,908
-
Total reported value
-
$469,458
-
Price per share
-
$7.46
-
Number of holders
-
2
-
Value change
-
+$223,114
-
Number of buys
-
1
Institutional Holders of ACELYRIN, Inc. - Common Stock (SLRN) as of Q4 2023
As of 31 Dec 2023 ACELYRIN, Inc. - Common Stock (SLRN) had 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 62,930 shares of stock of the company.
Largest 10 holders included AyurMaya Capital Management Company, LP, FMR LLC, CITADEL ADVISORS LLC, VANGUARD GROUP INC, Opaleye Management Inc., ORBIMED ADVISORS LLC, venBio Partners LLC, JPMORGAN CHASE & CO, Artal Group S.A., and BlackRock Inc..
This table shows 109 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.